Phase I study of TD-0714
Latest Information Update: 14 Nov 2016
At a glance
- Drugs TD 0714 (Primary)
- Indications Cardiovascular disorders; Kidney disorders
- Focus Adverse reactions
- 14 Nov 2016 New trial record
- 25 Oct 2016 According to Theravance Biopharma media release, the company expects to progress the IV formulation of TD-0714 into a Phase 1 study in the first half of 2017